Business
Result of ATM
MedPal AI plc has raised approximately £339,560 in gross proceeds through its At-The-Market equity issuance facility, issuing 6,500,000 new ordinary shares at an average price of 5.22p per share. These funds will bolster working capital for its online pharmaceutical subsidiary, MedPal Limited, enabling increased stock levels, product line expansion, and marketing initiatives for its pharmacy and clinic operations. To date, the company has raised a total of £1,216,655 via the ATM facility, which has a maximum limit of £2 million. The new shares are expected to be admitted to AIM and commence trading around 30 January 2026, bringing the total issued ordinary share capital to 440,099,640 shares. Disclaimer*
About this update from Medpal Ai Plc
[{"type":"text","content":"\n\n26 January 2026\nMedPal AI plc\n(\"MedPal AI\" or the \"Company\")\nUpdate on ATM Facility\n \nMedPal AI (AIM: MPAL), a UK-based digital health and artificial intelligence (\"AI\") company focused on health and wellness management, is pleased to provide an update on its At-The-Market (\"ATM\") equity issuance facility that it announced on 4 December 2025.\n \nThe Company has raised further gross proceeds of approximately £339,560 via the ATM facility through the issue of 6,500,000 new ordinary shares (\"ATM Shares\") at an average price of approximately 5.22p per ATM Share. The proceeds of the ATM facility will provide additional working capital for MedPal AI's recently established online pharmaceutical subsidiary, MedPal Limited, to hold greater levels of stock, expand product lines and to undertake marketing campaigns to grow the pharmacy and clinic parts of the business, MedPal Pharmacy and Medpal.clinic.\n \nFollowing this issue of shares, to date the Company has raised a total of £1,216,655 via the ATM facility, which enables the Company to raise up to £2 million subject to a minimum price per ATM Share of 5p. The announcement of 4 December 2025 can be viewed here irtools.co.uk/90/story/3ba161d5-8560-4c6d-8de9-a40e8eb9f1c1\n \nAdmission and Voting Rights\n \nApplication has been made for the 6,500,000 ATM Shares to be admitted to trading on AIM (\"Admission\"). Admission is expected to become effective and dealings in the ATM Shares are expected to commence on or around 30 January 2026.\n \nUpon Admission, the Company's issued ordinary share capital will consist of 440,099,640 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, from Admission the total number of Ordinary Shares and voting rights in the Company will be . With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.\n \nThis announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act...